Use of Radiopharmaceuticals in Diagnostic Nuclear Medicine in the United States
Vladimir Drozdovitch(National Cancer Institute), Steven L. Simon(National Institutes of Health), Allegra DePietro(University of Iowa Hospitals and Clinics), Martha S. Linet(National Institutes of Health), James A. Ponto(University of Iowa Hospitals and Clinics), Bennett S. Greenspan(Beth Israel Deaconess Medical Center), Steven C. Moore(National Cancer Institute), Milton D. Gross(Diabetes Australia), Stanley J. Goldsmith(United States Department of Health and Human Services), Jeffrey A. Clanton(Vanderbilt University), Marguerite T. Hays(United States Department of Health and Human Services), Ronald J. Callahan(University of Iowa Hospitals and Clinics), A.B. Brill(Argonne National Laboratory), Dunstana Melo, Walton W. Shreeve(Vanderbilt University)
Cited by 38
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
|Blood|2011|637
Hematotoxicity in Workers Exposed to Low Levels of Benzene
|Science|2004|623